Rubicon Research Limited (NSE:RUBICON)
1,362.20
+55.20 (4.22%)
At close: Jul 6, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 227.29 billion as of July 7, 2026.
Market Cap
227.29B
Enterprise Value
226.94B
Revenue
17.54B
Ranking
n/a
PE Ratio
90.11
Stock Price
1,362.20
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 227.29B, an increase of 119.61%. That is a compound annual growth rate of 197.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 224.42B | 100.10% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 549.30B |
| GlaxoSmithKline Pharmaceuticals | 405.35B |
| J. B. Chemicals & Pharmaceuticals | 379.44B |
| AstraZeneca Pharma India | 207.45B |
| Granules India | 206.45B |
| Caplin Point Laboratories | 192.72B |
| Jubilant Pharmova | 153.45B |
| Viyash Scientific | 128.41B |